Default object view. Click to create a custom template, Node ID: 125851, Object ID: 74104

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results...

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial

No relation

Yes

No relation

No

23/09/2015 3:11 pm

Supportive Care

No